🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluate the efficacy and safety of convers...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-03-17
Trial ID
NCT05099848
Treatments Being Tested
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Status
Recruiting
Location
Chinese PLA General hospital
Start Date
2021-01-01
Trial ID
NCT06333561
Try FOLFOX-HAIC combining bevacizumab or cetuximab for initially unresectab...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-05-01
Trial ID
NCT06988852
The purpose of this study is to evaluate the efficacy and safety of resecti...
Status
Unknown
Location
Dongguan People's Hospital
Start Date
2018-03-02
Trial ID
NCT03469479
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This study intends to evaluate the efficacy and safety of drug-eluting tran...
Status
Recruiting
Location
Chinese PLA General hospital
Start Date
2024-10-01
Trial ID
NCT06609863
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of hepatic...
Status
Unknown
Location
Dongguan People's Hospital
Start Date
2018-03-09
Trial ID
NCT03468231
Treatments Being Tested
This study was designed to evaluate the effectiveness and safety of hepatic...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-06-15
Trial ID
NCT05313282
The treatment options for unresectable HCC have rapidly developed, and immu...
Status
Unknown
Location
Hunan Provincial People's Hospital(The First Affiliated Hospital of Hunan Normal University)
Start Date
2024-03-03
Trial ID
NCT06364007
Treatments Being Tested